Delayed dexamethasone treatment at initiation of oxygen supplementation for coronavirus disease 2019 is associated with the exacerbation of clinical condition

INTRODUCTION: Coronavirus disease 2019 (COVID-19) frequently causes inflammatory lung injury as its symptoms progress. While dexamethasone reportedly reduces inflammation and prevents progression to respiratory failure, the appropriate time to administer dexamethasone in patients with COVID-19 remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibe, Yuta, Ishigo, Tomoyuki, Fujii, Satoshi, Fujiya, Yoshihiro, Kuronuma, Koji, Tsugawa, Takeshi, Takahashi, Satoshi, Fukudo, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930397/
https://www.ncbi.nlm.nih.gov/pubmed/35339384
http://dx.doi.org/10.1016/j.jiac.2022.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930397/
https://www.ncbi.nlm.nih.gov/pubmed/35339384
http://dx.doi.org/10.1016/j.jiac.2022.03.007

Ejemplares similares